Originalkatalog | Verfügbarkeit prüfen

Table1_Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier.DOCX

Melanie H. A. M. Perik, Emmanuela Govaerts, Steven Laga, Inge Goovaerts, Johan Saenen, Emeline Van Craenenbroeck, Josephina A. N. Meester, Ilse Luyckx, Inez Rodrigus, Aline Verstraeten, Lut Van Laer, Bart L. Loeys
2023

Originalkatalog | Verfügbarkeit prüfen

Table2_Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier.DOCX

Melanie H. A. M. Perik, Emmanuela Govaerts, Steven Laga, Inge Goovaerts, Johan Saenen, Emeline Van Craenenbroeck, Josephina A. N. Meester, Ilse Luyckx, Inez Rodrigus, Aline Verstraeten, Lut Van Laer, Bart L. Loeys
2023

Originalkatalog | Verfügbarkeit prüfen

Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier

Melanie H. A. M. Perik, Emmanuela Govaerts, Steven Laga, Inge Goovaerts, Johan Saenen, Emeline Van Craenenbroeck, Josephina A. N. Meester, Ilse Luyckx, Inez Rodrigus, Aline Verstraeten, Lut Van Laer, Bart L. Loeys
Veröffentlicht in: Frontiers in Genetics, Vol 14 (2023);
2023

Originalkatalog | Verfügbarkeit prüfen

Clinical and functional characterisation of a recurrent KCNQ1 variant in the Belgian population

Ewa Sieliwonczyk, Maaike Alaerts, Eline Simons, Dirk Snyders, Aleksandra Nijak, Bert Vandendriessche, Dorien Schepers, Dogan Akdeniz, Emeline Van Craenenbroeck, Katleen Knaepen, Laura Rabaut, Hein Heidbuchel, Lut Van Laer, Johan Saenen, Alain J. Labro, Bart Loeys
Veröffentlicht in: Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-12 (2023);
2023